An2 Therapeutics shares owned by TCG Crossover Management
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by TCG Crossover Management
from 13F filings
Historical chart of TCG Crossover Management investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in An2 Therapeutics by TCG Crossover Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $43M | 2.7M | 16.08 |
2023-06-30 | $11M | 1.3M | 8.50 |